La Revue du praticien · 2008
[Treatment of systemic vasculitides].
Сравнительное исследованиеАннотация на английскомСтатьяОбзорНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Guillevin Lïc, Pagnoux Christian
Аннотация
The treatment of necrotizing vasculitides may be based on several drugs, depending on the disease itself, its severity, its etiology and the expected prognosis. In practice, the least severe forms, associated with a prognostic score of 0, may be treated with corticosteroids only, while the ones associated with severity factors should be treated with an association of corticosteroids and immunosuppressants. The first-line treatment of viral-associated vasculitides should be based on antiviral drugs. The treatment duration of non-infectious vasculitides is typically 18 to 24 months. The improvement in prognosis is due to the treatment as well as to anti-infectious prophylaxis and careful management of potential complications.
Предметные рубрики MeSH
Adrenal Cortex HormonesAnti-Inflammatory Agents, Non-SteroidalAntiviral AgentsAzathioprineChurg-Strauss SyndromeClinical Trials as TopicCryoglobulinemiaCyclophosphamideDrug Therapy, CombinationEtanerceptGranulomatosis with PolyangiitisHepatitis BHumansImmunoglobulin GImmunoglobulins, IntravenousImmunosuppressive AgentsInterferonsPlasma ExchangePolyarteritis NodosaPrognosisProspective StudiesReceptors, Tumor Necrosis FactorRecurrenceRibavirinRiskSeverity of Illness IndexTime FactorsTumor Necrosis Factor-alphaVasculitisVirus Diseases